These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12593867)

  • 1. Assessing the quality of life of patients in phase I and II anti-cancer drug trials: interviews versus questionnaires.
    Cox K
    Soc Sci Med; 2003 Mar; 56(5):921-34. PubMed ID: 12593867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants' experiences.
    Cox K
    Psychooncology; 2000; 9(4):314-22. PubMed ID: 10960929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How did partners experience cancer patients' participation in a phase I study? An observational study after a patient's death.
    Langenberg SM; Peters ME; van der Graaf WT; Wymenga AN; Prins JB; van Herpen CM
    Palliat Support Care; 2016 Jun; 14(3):241-9. PubMed ID: 26675215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative assessment of the experience of participating in a cancer-related clinical trial.
    Wootten AC; Abbott JM; Siddons HM; Rosenthal MA; Costello AJ
    Support Care Cancer; 2011 Jan; 19(1):49-55. PubMed ID: 19960208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.
    Nurgat ZA; Craig W; Campbell NC; Bissett JD; Cassidy J; Nicolson MC
    Br J Cancer; 2005 Mar; 92(6):1001-5. PubMed ID: 15770219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.
    van der Biessen DA; van der Helm PG; Klein D; van der Burg S; Mathijssen RH; Lolkema MP; de Jonge MJ
    Psychooncology; 2018 Jan; 27(1):163-170. PubMed ID: 28665008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the quality of life of patients in phases I and II anti-cancer drug trials: interviews versus questionnaires by Cox K.
    McKenna SP
    Soc Sci Med; 2004 Feb; 58(3):659-60; author reply 661. PubMed ID: 14652062
    [No Abstract]   [Full Text] [Related]  

  • 8. Self-reported quality of life and hope in phase-I trial participants: An observational prospective cohort study.
    van der Biessen DA; Oldenmenger WH; van der Helm PG; Klein D; Oomen-de Hoop E; Mathijssen RH; Lolkema MP; de Jonge MJ
    Eur J Cancer Care (Engl); 2018 Nov; 27(6):e12908. PubMed ID: 30179287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
    Carlson LE; Bultz BD; Morris DG
    Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials.
    Cox K
    Patient Educ Couns; 2002 Jan; 46(1):31-8. PubMed ID: 11804767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intervention to improve cancer patients' understanding of early-phase clinical trials.
    Kass NE; Sugarman J; Medley AM; Fogarty LA; Taylor HA; Daugherty CK; Emerson MR; Goodman SN; Hlubocky FJ; Hurwitz HI; Carducci M; Goodwin-Landher A
    IRB; 2009; 31(3):1-10. PubMed ID: 19552233
    [No Abstract]   [Full Text] [Related]  

  • 12. The experience of older patients with cancer in phase 1 clinical trials: a qualitative case series.
    Kvale EA; Woodby L; Williams BR
    Am J Hosp Palliat Care; 2010 Nov; 27(7):474-81. PubMed ID: 20388935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of measuring quality of life in phase I/II trials of cancer therapy--the effects of antibody targeted therapy: Part I.
    Hope-Stone LD; Napier MP; Begent RH; Cushen N; O'Malley D
    Eur J Cancer Care (Engl); 1997 Dec; 6(4):267-72. PubMed ID: 9460345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study.
    Brédart A; Bodson S; Le Tourneau C; Flahault C; Bonnetain F; Beaudeau A; Coquan E; Dolbeault S; Paoletti X
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27734561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient attitudes to clinical trials: development of a questionnaire and results from asthma and cancer patients.
    Jenkinson C; Burton JS; Cartwright J; Magee H; Hall I; Alcock C; Burge S
    Health Expect; 2005 Sep; 8(3):244-52. PubMed ID: 16098154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation.
    Godskesen T; Nygren P; Nordin K; Hansson M; Kihlbom U
    Support Care Cancer; 2013 Nov; 21(11):3137-42. PubMed ID: 23864288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
    Kimman ML; Rotteveel AH; Wijsenbeek M; Mostard R; Tak NC; van Jaarsveld X; Storm M; Wijnsma KL; Gelens M; van de Kar NCAJ; Wetzels J; Dirksen CD
    Patient; 2017 Oct; 10(5):629-642. PubMed ID: 28357591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trials in cancer patients: participants' perceptions.
    Hutchison C
    Eur J Cancer Care (Engl); 1998 Mar; 7(1):15-22. PubMed ID: 9582747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.